Publications by authors named "E Martinelli"

Claim this Profile
N
Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer patients: demystifying the 100% clinical complete response paradigm.
Federica Marmorino, Federica Morano, Maria Anna Canciello, Piercarlo Rossi, Annalice Gandini, Erika Martinelli

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.
E Elez, S Siena, A Sartore-Bianchi, J Ros, F Ciardello, E Martinelli

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.
D Ciardiello, G Martini, L Boscolo Bielo, F Pietrantonio, A Raimondi, E Martinelli

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agnostic phase II, multicenter, single-arm study with DURVAlumab plus carboplatin or cisplatin and etoposide as first-line treatment in extensive stage - Extrapulmonary Small Cell Carcinoma (EPSCC) patients - DURVASCC trial (GOIRC-01-2021).
Angela Damato, Giuseppe Maglietta, Lorenzo Antonuzzo, Rossana Berardi, Angela Buonadonna, Erika Martinelli

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial).
Valerio Nardone, Vittorio Patanè, Luca Marinelli, Luca D'Ambrosio, Sara Del Tufo, Erika Martinelli

Diagnostics (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis